Nuclear stress testing may identify those likely to benefit from early revascularization

Early revascularization may confer mortality benefit in patients with moderate to severe myocardial ischemia identified on nuclear stress testing, regardless of left ventricular ejection fraction, researchers reported.
However, early revascularization for patients with no myocardial ischemia or mild myocardial ischemia on nuclear stress testing was not associated with mortality benefits, according to data published in the Journal of the American College of Cardiology.
“There is keen interest in assessing how measurement of myocardial ischemia during stress testing can help shape physicians’